US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Inspire Corporate Bond ETF

23.15

-0.0166-0.07%

Volume:38.59K

Turnover:895.49K

Market Cap:500.18M

PE:- -

High:23.39

Open:23.34

Low:23.14

Close:23.17

52wk High:24.78

52wk Low:22.94

Shares:21.60M

Float Shares:21.60M

Volume Ratio:1.03

T/O Rate:0.18%

Dividend:1.01

Dividend Rate:4.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance

Palisade Bio to Participate in Upcoming Investor Conferences

How to Put Out Wildfires Fueled by World War II Ammo? Try Driverless Tanks.

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/IBD"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","market":"US","secType":"STK","nameCN":"Inspire Corporate Bond ETF","latestPrice":23.1534,"timestamp":1790271332017,"preClose":23.17,"halted":0,"volume":38591,"delay":0,"changeRate":-0.0007164436771687696,"floatShares":21602767,"shares":21602767,"eps":0,"marketStatus":"Trading","change":-0.0166,"latestTime":"09-24 13:43:30 EDT","open":23.3401,"high":23.39,"low":23.1396,"amount":895493.619657,"amplitude":0.010807,"askPrice":23.19,"askSize":300,"bidPrice":23.15,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790280000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":23.17,"sharesOutstanding":19800000,"nav":23.31,"aum":503512003.43,"dividendRate":0.043812,"bidAskSpread":0.001958,"preHourTrading":{"tag":"盘前","latestPrice":23.17,"preClose":23.17,"latestTime":"08:47 EDT","volume":5,"amount":115.85000000000001,"timestamp":1790254028172,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":23.17,"preClose":23.17,"latestTime":"19:30 EDT","volume":12,"amount":278.04,"timestamp":1790206202458,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.033079},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","floatShares":21602767,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.033079,"shares":21602767,"dividePrice":1.0144,"high":23.39,"amplitude":0.010807,"preClose":23.17,"low":23.1396,"week52Low":22.9401,"pbRate":"--","week52High":24.78,"institutionHeld":0,"latestPrice":23.1534,"committee":-0.5,"eps":0,"divideRate":0.043812,"volume":38591,"delay":0,"ttmEps":0,"open":23.3401,"prevYearClose":24.2,"prevWeekClose":23.32,"prevMonthClose":23.53,"prevQuarterClose":23.77,"fiveDayClose":23.352,"twentyDayClose":23.6384,"sixtyDayClose":23.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBD\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"IBD","amount":0.0904,"announcedDate":"2026-08-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-26","defaultRemindTime":1787751000000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-26","currency":"USD","dateTimestamp":1787716800000,"payDate":"2026-08-31"},{"date":"2026-07-24","symbol":"IBD","amount":0.0762,"announcedDate":"2026-07-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-24","defaultRemindTime":1784899800000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-29","payableDate":"2026-07-24","currency":"USD","dateTimestamp":1784865600000,"payDate":"2026-07-29"},{"date":"2026-06-26","symbol":"IBD","amount":0.0959,"announcedDate":"2026-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-26","defaultRemindTime":1782480600000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-01","payableDate":"2026-06-26","currency":"USD","dateTimestamp":1782446400000,"payDate":"2026-07-01"},{"date":"2026-05-22","symbol":"IBD","amount":0.0776,"announcedDate":"2026-05-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-22","defaultRemindTime":1779456600000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-05-22","currency":"USD","dateTimestamp":1779422400000,"payDate":"2026-05-27"},{"date":"2026-04-24","symbol":"IBD","amount":0.0788,"announcedDate":"2026-04-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-24","defaultRemindTime":1777037400000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-29","payableDate":"2026-04-24","currency":"USD","dateTimestamp":1777003200000,"payDate":"2026-04-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBD\",market:\"US\",,,undefined,":[{"executeDate":"2017-08-16","recordDate":"2017-08-18","paymentDate":"2017-08-23","value":0.0405,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-25","value":0.0292,"currency":"USD"},{"executeDate":"2017-10-16","recordDate":"2017-10-17","paymentDate":"2017-10-23","value":0.0347,"currency":"USD"},{"executeDate":"2017-11-16","recordDate":"2017-11-17","paymentDate":"2017-11-28","value":0.0389,"currency":"USD"},{"executeDate":"2018-01-29","recordDate":"2018-01-30","paymentDate":"2018-02-05","value":0.0269,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBD\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669486662","title":"Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486662","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486662?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:45","pubTimestamp":1790167500,"startTime":"0","endTime":"0","summary":"Canadian clearance supports site activation and enrollment in the global study of once-daily oral PALI-2108 Primary efficacy results from approximately 204 patients with moderately to severely active ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367474/0/en/palisade-bio-expands-global-phase-2b-ascentra-uc-program-with-health-canada-cta-clearance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","BK4116","BK4023","JPFP","TFPN","DBMF","ISMF","BK4127","SDMF","CD","IBD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664771228","title":"Palisade Bio to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664771228","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664771228?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:00","pubTimestamp":1788440400,"startTime":"0","endTime":"0","summary":"Denver, CO, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation prodrugs for pati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355949/0/en/palisade-bio-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","CD","BK4116","IBD","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660874612","title":"How to Put Out Wildfires Fueled by World War II Ammo? Try Driverless Tanks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660874612","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660874612?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:30","pubTimestamp":1787232600,"startTime":"0","endTime":"0","summary":"Ed BallardConsuming a few hundred acres, the fire in the Hürtgen Forest, western Germany, was a mere barbecue compared with the conflagrations that have recently threatened Mediterranean tourist spots","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660178421","title":"Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660178421","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660178421?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:26","pubTimestamp":1787142360,"startTime":"0","endTime":"0","summary":"Proposed merger with Scipher Medicine to assess nebokitug in a Phase 2 precision medicine trial in rheumatoid arthritis (RA) continues to advance with closing expected byyear-end RA is a $24 billion m","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347616/0/en/chemomab-therapeutics-announces-second-quarter-2026-financial-results-and-provides-corporate-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTRS","BK4539","IBD","BK4139","BK4007","RA","PSC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBD\",params:#limit:6,delay:false,,,undefined,":[]}}